$CBAY CymaBay Therapeutics, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CymaBay Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in CymaBay Therapeutics, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
CymaBay Therapeutics, Inc. Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
Booth Robert F. | Director | 0 | 0 | Jan 31 2019 | |||
Boudes Pol F | Chief Medical Officer | 0 | 0 | Jan 31 2019 | |||
Boudes Pol F | Chief Medical Officer | 0 | 0 | Apr 16 2014 | |||
Boudes Pol F | Chief Medical Officer | 0 | 0 | Jan 27 2015 | |||
Dickinson Klara | Chief Regulatory Officer | 0 | 0 | Jan 28 2021 | |||
Dorling Janet | Chief Commercial Officer | 0 | 0 | Aug 05 2019 | |||
EMSTER KURT VON | Director | 184,528 | 378,282 | Feb 01 2021 | |||
GOLDFISCHER CARL | Director | 2,335 | 4,787 | Feb 08 2019 | |||
GOLDFISCHER CARL | Director | 0 | 0 | Jan 15 2014 | |||
GOLDFISCHER CARL | Director | 0 | 0 | Jan 08 2015 | |||
Kumar Hari | Director | 0 | 0 | Jun 30 2015 | |||
Kumar Hari | Director | 0 | 0 | Jan 08 2015 | |||
LANGE LOUIS G | Director | 0 | 0 | Jun 30 2015 | |||
LANGE LOUIS G | Director | 0 | 0 | Jan 15 2014 | |||
LANGE LOUIS G | Director | 0 | 0 | Jan 08 2015 | |||
Loewy Caroline M | Director | 0 | 0 | Jan 28 2021 | |||
Martin Robert L. | SVP, Nonclinical & Manuf. | 0 | 0 | Jan 26 2018 | |||
McWherter Charles | Chief Scientific Officer | 10,300 | 21,115 | Jan 28 2021 | |||
McWherter Charles | Sr. Vice President | 0 | 0 | Jan 08 2015 | |||
Menold Daniel | Vice President, Finance | 5,000 | 10,250 | Jan 28 2021 | |||
OMara Patrick J. | SVP, Business Development | 5,022 | 10,295 | Jan 26 2018 | |||
PENHOET EDWARD | Director | 0 | 0 | Jan 08 2015 | |||
Quinlan Paul T | General Counsel | 0 | 0 | Jan 28 2021 | |||
Rosemark Kirk | V.P. Regulatory & Quality | 0 | 0 | Jan 23 2017 | |||
Shah Sujal | Chief Executive Officer | 120,000 | 246,000 | Jan 28 2021 | |||
Shah Sujal | Chief Financial Officer | 10,000 | 20,500 | Jan 08 2015 | |||
STEIN EVAN A. | Director | 0 | 0 | Jan 31 2019 | |||
STUART LEWIS J | Chief Commercial Officer | 0 | 0 | May 10 2021 | |||
TRUEX PAUL F | Director | 0 | 0 | Jan 28 2021 | |||
Van Wart Harold | President and CEO | 7,958 | 16,314 | Jan 23 2017 | |||
Van Wart Harold | President and CEO | 0 | 0 | Jan 08 2014 | |||
Van Wart Harold | President and CEO | 0 | 0 | Jan 08 2015 | |||
von Emster Kurt | Director | 90,000 | 184,500 | May 19 2020 | |||
von Emster Kurt | Director | 0 | 0 | Jan 08 2015 | |||
Weiland Robert J. | Director | 0 | 0 | Jan 31 2019 | |||
WIGGANS THOMAS G | Director | 0 | 0 | Apr 05 2021 | |||
Wills Robert James | Director | 25,200 | 51,660 | Jan 28 2021 |